Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin

A triple therapy based on a proton pump inhibitor (PPI), amoxicillin (AMPC), and clarithromycin (CAM) is recommended as a first-line therapy for Helicobacter pylori (H. pylori) eradication and is widely used in Japan. However, a decline in eradication rate associated with an increase in prevalence o...

Full description

Bibliographic Details

Published in:	Journal of Clinical Biochemistry and Nutrition Vol. 47; no. 1; pp. 53 - 58
Main Authors:	Sasaki, Makoto, Ogasawara, Naotaka, Utsumi, Keiko, Kawamura, Naohiko, Kamiya, Tskeshi, Kataoka, Hiromi, Tanida, Satoshi, Mizoshita, Tsutomu, Kasugai, Kunio, Joh, Takashi
Format:	Journal Article
Language:	English
Published:	Japan SOCIETY FOR FREE RADICAL RESEARCH JAPAN 01-07-2010 Japan Science and Technology Agency the Society for Free Radical Research Japan
Subjects:	amoxicillin clarithromycin resistance Helicobacter pylori Original proton pump inhibitor triple therapy amoxicillin Helicobacter pylori triple therapy proton pump inhibitor clarithromycin resistance
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!